10x Genomics, Inc. (TXG) Financial Statements (2024 and earlier)

Company Profile

Business Address 6230 STONERIDGE MALL ROAD
PLEASANTON, CA 94588
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments429,984587,447663,603424,166
Cash and cash equivalents219,746587,447663,603424,166
Short-term investments210,238   
Restricted cash and investments2,6331,02816,567 
Receivables104,21185,25451,20833,371
Inventory, net of allowances, customer advances and progress billings81,62959,96629,95915,270
Inventory81,62959,96629,95915,270
Other undisclosed current assets16,57813,89613,0298,033
Total current assets:635,035747,591774,366480,840
Noncurrent Assets
Operating lease, right-of-use asset69,88260,91846,983 
Property, plant and equipment289,328169,49272,84048,821
Intangible assets, net (including goodwill)27,36929,908  
Goodwill4,5114,511  
Intangible assets, net (excluding goodwill)22,85825,397  
Restricted cash and investments4,9747,5988,47452,327
Other noncurrent assets2,3923,31926,67823,935
Total noncurrent assets:393,945271,235154,975125,083
TOTAL ASSETS:1,028,9801,018,826929,341605,923
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities71,26367,60135,43730,174
Taxes payable4,6228,6491,087
Employee-related liabilities31,62615,38312,394
Accounts payable21,59917,3514,70913,028
Accrued liabilities49,66414,0026,6963,665
Deferred revenue7,8675,3404,4723,297
Debt    9,882
Deferred compensation liability   247494
Estimated litigation liability   44,173 
Other liabilities6,7075,2755,8443,949
Other undisclosed current liabilities45,12032,14127,95315,253
Total current liabilities:130,957110,357118,12663,049
Noncurrent Liabilities
Long-term debt and lease obligation  76,84757,04219,837
Long-term debt, excluding current maturities    19,837
Liabilities, other than long-term debt92,2808,2403,93018,045
Deferred revenue    834
Deferred rent credit    16,120
Other liabilities6,1418,2403,9301,091
Operating lease, liability86,13976,84757,042 
Other undisclosed noncurrent liabilities  5,81411,17184,909
Total noncurrent liabilities:92,28090,90172,143122,791
Total liabilities:223,237201,258190,269185,840
Equity
Equity, attributable to parent805,743817,568739,072420,083
Common stock2222
Additional paid in capital1,839,3971,680,8651,544,218682,494
Accumulated other comprehensive income (loss)(4,335)22(50)(46)
Accumulated deficit(1,029,321)(863,321)(805,098)(262,367)
Total equity:805,743817,568739,072420,083
TOTAL LIABILITIES AND EQUITY:1,028,9801,018,826929,341605,923

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues516,409490,490298,845245,893
Cost of revenue(120,386)(74,091)(58,468)(61,033)
Gross profit:396,023416,399240,377184,860
Operating expenses(563,967)(468,652)(774,519)(215,433)
Operating loss:(167,944)(52,253)(534,142)(30,573)
Nonoperating income (expense)5,973(1,462)(334)(460)
Investment income, nonoperating6,6472061,5322,805
Other nonoperating income (expense)(198)(802)1,337(186)
Interest and debt expense(476)(866)(1,521)(3,079)
Loss from continuing operations before equity method investments, income taxes:(162,447)(54,581)(535,997)(34,112)
Other undisclosed income from continuing operations before income taxes4768661,5213,079
Loss from continuing operations before income taxes:(161,971)(53,715)(534,476)(31,033)
Income tax expense(4,029)(4,508)(8,255)(218)
Loss from continuing operations:(166,000)(58,223)(542,731)(31,251)
Loss before gain (loss) on sale of properties:(58,223)(542,731)(31,251)
Net loss available to common stockholders, diluted:(166,000)(58,223)(542,731)(31,251)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(166,000)(58,223)(542,731)(31,251)
Comprehensive loss:(166,000)(58,223)(542,731)(31,251)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(4,357)72(4)(9)
Comprehensive loss, net of tax, attributable to parent:(170,357)(58,151)(542,735)(31,260)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: